APA (7th ed.) Citation

R, B., AMW, S., H, G., A, B., L, C., A, B., . . . K, S. (2024). Differences in SARS-CoV-2 antibody prevalence at the end of the pre-vaccination period between age groups: A cross-sectional analysis of the multi-ethnic population-based HELIUS study. PloS one, 19(10), e0311196. https://doi.org/10.1371/journal.pone.0311196

Chicago Style (17th ed.) Citation

R, Bolijn, Spijkerman AMW, Galenkamp H, Blokstra A, Coyer L, Boyd A, Prins M, and Stronks K. "Differences in SARS-CoV-2 Antibody Prevalence at the End of the Pre-vaccination Period Between Age Groups: A Cross-sectional Analysis of the Multi-ethnic Population-based HELIUS Study." PloS One 19, no. 10 (2024): e0311196. https://doi.org/10.1371/journal.pone.0311196.

MLA (9th ed.) Citation

R, Bolijn, et al. "Differences in SARS-CoV-2 Antibody Prevalence at the End of the Pre-vaccination Period Between Age Groups: A Cross-sectional Analysis of the Multi-ethnic Population-based HELIUS Study." PloS One, vol. 19, no. 10, 2024, p. e0311196, https://doi.org/10.1371/journal.pone.0311196.